English
  • banner
  • banner

Retatrutide 5mg

Retatrutide 5mg Featured Image
  • Retatrutide 5mg
  • Retatrutide 5mg
  • Retatrutide 5mg
  • Retatrutide 5mg

Retatrutide 5mg

Short Description:

Retatrutide is a novel investigational triple-hormone receptor agonist developed by Eli Lilly and Company, representing a significant advancement in metabolic therapeutics. It is designed as a once-weekly subcutaneous injection that simultaneously targets the GLP-1, GIP, and glucagon receptors, offering a multi-faceted approach to managing body weight and glucose levels. This product is positioned as a next-generation therapy for individuals who have not achieved sufficient results with existing dual-agonist or single-agonist treatments, aiming to provide deeper and more sustained metabolic improvements.

请先在后台设置Paypal收款账户，然后刷新页面！


  • :

    • Product Detail

    FAQ

    Product Tags

    Technical Specifications

    Item Specification
    Product Name Retatrutide
    CAS NO. 2381089-83-2
    Appearance White to off-white lyophilized powder
    Molecular Formula C221H342N46O68
    Molecular Weight 4731.33 g/mol
    Purity (RP-HPLC) ≥98.0%
    Solubility Soluble in water or 0.9% saline solution; compatible with standard buffers
    Endotoxin ≤ 0.1 EU/mg
    Biological Activity Potent agonist for GLP-1, GIP, and glucagon receptors; promotes weight loss & glucose control
    Storage Conditions Store at 2–8°C protected from light; avoid repeated freeze-thaw cycles
    Stock Location Stock in USA
    MOQ 1g

    1. MECHANISM OF ACTION

    The mechanism of action of Retatrutide is characterized by its unique triple-agonist profile, which integrates the effects of three key metabolic hormones. By activating GLP-1 receptors, it enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner while slowing gastric emptying to increase satiety; through GIP receptor agonism, it improves insulin sensitivity and may potentiate the effects on adipose tissue; and critically, by activating the glucagon receptor, it increases energy expenditure and promotes lipolysis, thereby creating a synergistic effect that not only reduces appetite but also actively burns stored fat.

    2. PRODUCT INDICATIONS

    Retatrutide is indicated for the treatment of adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity, as well as for the management of type 2 diabetes mellitus. It is particularly suitable for patients seeking substantial weight loss beyond what is typically achievable with lifestyle modifications or first-line pharmacotherapies, including those who may be considering bariatric surgery but prefer a non-surgical alternative, and individuals requiring robust glycemic control alongside significant body weight reduction.

    ★ 3. CLINICAL EFFICACY OF PRODUCT

    Clinical trial data, notably from the Phase 2 TRIUMPH study, demonstrate that Retatrutide achieves unprecedented levels of weight reduction, with up to 24.2% mean body weight loss at 48 weeks at the 12 mg dose, and over 30% weight loss observed in a significant proportion of participants at 72 weeks. For glycemic control, it achieved HbA1c reductions of up to 2.02%, significantly outperforming active comparators like dulaglutide.

    4. Certificate

    GlobalTech Co., Ltd. is committed to providing high-purity biotechnological peptide products, adhering strictly to quality standards and obtaining internationally recognized certifications.

    1. A rigorous quality management system
    2. Batch traceability and stability data
    3. Professional laboratory testing and validation
    4. Compliance with international trade standards

    Each batch includes COA, HPLC purity report, MS chromatograms, and third-party testing reports.

    5. DELIVERY & SHIPPING

    Professional and Secure Packaging

    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation. We can also customize packaging according to customer needs.

    Shipping Methods

    Main Method: International Air Freight (DHL, FedEx, UPS, TNT). Air freight ensures the fastest transit time and minimizes environmental impact.

    Global Technology Co., Ltd. is a modern and advanced enterprise specializing in the production and export of active pharmaceutical ingredients (APIs), peptides, and plant extracts. The company invests in and collaborates closely with domestic manufacturers holding GMP, DMF, and FDA certifications.

    HotTags: Retatrutide, TripleAgonist, ObesityTreatment, Type2Diabetes, WeightLossJourney, GLP1Agonist, MetabolicHealth, EliLilly, ClinicalTrials, NewDrug, FatLoss, IncretinTherapy Supplier, Manufacturer, Bulk order, Pharmaceutical.
    Contact Us: info@huanqiukeji9.com | WhatsApp: 85246842553

    Does Retatrutide Actually Burn Fat?

    Retatrutide is an experimental medication being studied for obesity and metabolic disease. It activates three key hormone receptors: GLP-1, GIP, and glucagon. By stimulating GLP-1 and GIP pathways, it significantly reduces hunger and food intake. At the same time, its glucagon receptor activity may slightly increase energy expenditure. This combination creates a sustained calorie deficit, which leads to fat loss. In summary, it creates biological conditions that lead the body to gradually reduce stored fat.

    Retatrutide Benefits

    One of the most notable benefits is substantial weight loss, often exceeding results seen with Tirzepatide. Beyond weight management, it has demonstrated improvements in metabolic health, lowering blood glucose levels and improving insulin sensitivity. It also shows potential in reducing liver fat and improving cardiovascular risk factors like triglycerides and LDL cholesterol.

    Retatrutide How to Get

    Retatrutide is still an investigational drug and has not yet received full regulatory approval from agencies like the FDA. The primary way to access it right now is through participation in clinical trials. It is important to be cautious about online sources claiming to sell retatrutide, as unregulated products may be unsafe or counterfeit.

    Retatrutide is a novel investigational triple-hormone receptor agonist developed by Eli Lilly and Company, representing a significant advancement in metabolic therapeutics. It is designed as a once-weekly subcutaneous injection that simultaneously targets the GLP-1, GIP, and glucagon receptors.

    请先在后台设置Paypal收款账户，然后刷新页面！

  • Previous:
  • Next:

    • Besides, you can contact us if you have any other questions

    Q1: Can i get some samples?

    A: Yes, we can supply the free sample, but the shipping cost be paid by our customers.

    Q2: How to start orders or make payments?

    A: Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T, Western Unionor Paypal or Escrow(Alibaba).

    Q3: How to confirm the Product Quality before placing orders?

    A:You can get free samples for some products,you only need to pay the shipping costor arrange a courier to us and take the samples. You can send us your product specifi-cations and requests,we will manufacture the products according to your requests.

    Q4:What’s your MOQ?

    A:Our MOQ is 1kg. But usually we accept less quantity such as 100g on the conditionthat sample charge is 100% paid.

    Q5: How about delivery lead time?

    A: Delivery lead time: About 1-3 days after payment confirmed. (Chinese holiday notincluded)

    • Write your message here and send it to us

    HOT-SALE PRODUCT

    Quality First, Safety Guaranteed